HPK1-IN-22 structure
|
Common Name | HPK1-IN-22 | ||
---|---|---|---|---|
CAS Number | 2380300-79-6 | Molecular Weight | 462.61 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C26H30N4O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HPK1-IN-22HPK1-IN-22 (compound ZYF0033) is a hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC50 less than 10 nM based on the phosphorylation inhibition of MBP protein. HPK1-IN-22 decreases the phosphorylation of SLP76 (serine 376). HPK1-IN-22 promotes anticancer immune responses.HPK1-IN-22 inhibits tumor growth and caused increases intratumoral infiltration of DCs, NK cells, and CD107a+CD8+ T cells but decreased infiltration of regulatory T cells, PD-1+CD8+ T cells, TIM-3+CD8+ T cells, and LAG3+CD8+ T cells in the 4T-1 syngeneic mouse model[1]. |
Name | HPK1-IN-22 |
---|
Description | HPK1-IN-22 (compound ZYF0033) is a hematopoietic progenitor kinase 1 (HPK1) inhibitor with an IC50 less than 10 nM based on the phosphorylation inhibition of MBP protein. HPK1-IN-22 decreases the phosphorylation of SLP76 (serine 376). HPK1-IN-22 promotes anticancer immune responses.HPK1-IN-22 inhibits tumor growth and caused increases intratumoral infiltration of DCs, NK cells, and CD107a+CD8+ T cells but decreased infiltration of regulatory T cells, PD-1+CD8+ T cells, TIM-3+CD8+ T cells, and LAG3+CD8+ T cells in the 4T-1 syngeneic mouse model[1]. |
---|---|
Related Catalog | |
Target |
HPK1:<10 nM (IC50) |
References |
Molecular Formula | C26H30N4O2S |
---|---|
Molecular Weight | 462.61 |